YORK: Abingdon Health plc (AIM: ABDX) and Bimelix Ab announced a strategic collaboration to develop, manufacture and commercialise a Lyme disease lateral flow self-test (LFT). Abingdon and Bimelix have been collaborating for over 12 months on the feasibility of developing a Lyme disease LFT self-test. Under the terms of the agreement, Abingdon and Bimelix will…
Tag: Abingdon Health
Abingdon Health signs strategic collaboration with DeepVerge plc
YORK: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a Memorandum of Understanding (“MoU”) with DeepVerge plc (AIM: DVRG) (“DeepVerge”), an environmental and life science group that develops and applies AI and IoT technology for the analysis and identification of bacteria, virus and…
Abingdon Health plc signs strategic collaboration with Vatic Health Limited
YORK: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a Memorandum of Understanding (“MoU”) with leading diagnostic technology innovator Vatic Health Limited (“Vatic”), leading to a commercial agreement for the development and manufacture of a range of lateral flow tests (“LFTs”) in the…